InMode Ltd. (INMD)
| Previous close | 17.23 |
| Open | 17.01 |
| Bid | 17.15 x 200 |
| Ask | 17.26 x 300 |
| Day's range | 16.84 - 17.21 |
| 52-week range | 16.82 - 48.25 |
| Volume | |
| Avg. volume | 1,544,369 |
| Market cap | 1.455B |
| Beta (5Y monthly) | 2.16 |
| PE ratio (TTM) | 7.48 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
InMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTL
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, responded to the recent petition to the U.S. Patent & Trademark Office filed by BTL Industries, Inc., in which BTL asks the USPTO to conduct an Inter Partes Review of InMode's U.S. Patent No. 8,961,511. Six months before BTL's petition, InMode sued BTL in the United States District Court for the Central District of California alleging that BTL's UltraFemme 360 and EmFemme 360 non-invasive, radio-frequency b
- PR Newswire
InMode to Report First Quarter 2024 Financial Results and Hold Conference Call May 2, 2024
InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the first quarter of 2024 before the Nasdaq market opens on Thursday, May 2, 2024.
- PR Newswire
InMode to Present at Upcoming Investor Conferences and Events
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences and events in April and May:
